BOOZ ALLEN HAMILTON INC

Federal contract award, Booz Allen Hamilton, $1,537,700

Key CONT_AWD_75F40125F19006_7524_75F40124A00001_7524. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 24 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/booz-allen-hamilton/CONT_AWD_75F40125F19006_7524_75F40124A00001_7524
At the source https://www.usaspending.gov/award/CONT_AWD_75F40125F19006_7524_75F40124A00001_7524
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:53:25Z
Content hash 324b50d9868ce1bd8a2c267e66577bd6a82bb2fdf4c78d342bff8d2070cf4751

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$1,537,700first versionAugust 12, 2025August 12, 20262026-09-05T00:53:25Zhistorical sweep324b50d9868c

Archived copy

None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.

What the amount is made of

4 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-15, when USAspending reported a total obligation of $1,537,700.

Action dateModificationTypeObligatedDescription as recorded
August 12, 2026P00003ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED)+$94,992DEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT
July 22, 2026P00002EXERCISE AN OPTION+$647,455DEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT
September 2, 2025P00001OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT
August 12, 2025basenot on file+$795,254DEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT

Last refreshed November 4, 2026 at 2:31 PM UTC.